glucagon has been researched along with Adrenocorticotropic Hormone, Inappropriate Secretion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbot, M; Basso, D; Ceccato, F; Giordano, C; Guarnotta, V; Mondin, A; Regazzo, D; Scaroni, C | 1 |
| Atkinson, B; Bertherat, J; Biller, BM; Boscaro, M; Darby, CH; Findling, J; Freda, PU; Frohman, LA; Glusman, JE; Grossman, AB; Hu, K; Ludlam, WH; Melmed, S; Petersenn, S; Reincke, M; Snyder, P; Tabarin, A; Wang, Y | 1 |
1 trial(s) available for glucagon and Adrenocorticotropic Hormone, Inappropriate Secretion
| Article | Year |
|---|---|
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Blood Glucose; Female; Glucagon; Humans; Hydrocortisone; Insulin; Male; Middle Aged; Oligopeptides; Pituitary ACTH Hypersecretion; Somatostatin | 2009 |
1 other study(ies) available for glucagon and Adrenocorticotropic Hormone, Inappropriate Secretion
| Article | Year |
|---|---|
Incretin Response to Mixed Meal Challenge in Active Cushing's Disease and after Pasireotide Therapy.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Incretins; Insulin; Insulin Resistance; Meals; Pituitary ACTH Hypersecretion; Somatostatin | 2022 |